| GC46607-5mg |
|
64091-91-4 |
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
|
0 |
C10H13N3O2 |
|
|
|
| GC46606-10g |
|
214360-73-3 |
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaboran-2yl)aniline
|
0 |
C12H18BNO2 |
|
|
|
| GC46606-5g |
|
214360-73-3 |
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaboran-2yl)aniline
|
0 |
C12H18BNO2 |
|
|
|
| GC46606-1g |
|
214360-73-3 |
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaboran-2yl)aniline
|
0 |
C12H18BNO2 |
|
|
|
| GC46605-10mg |
|
— |
|
0 |
C24H36D4O5 |
|
|
|
| GC46605-5mg |
|
— |
|
0 |
C24H36D4O5 |
|
|
|
| GC46605-1mg |
|
— |
|
0 |
C24H36D4O5 |
|
|
|
| GC46605-500μg |
|
— |
|
0 |
C24H36D4O5 |
|
|
|
| GC46604-5mg |
|
404-82-0 |
3-trifluoromethyl-N-Ethylamphetamine (hydrochloride)
|
0 |
C12H16F3N.HCl |
|
|
|
| GC46604-1mg |
|
404-82-0 |
3-trifluoromethyl-N-Ethylamphetamine (hydrochloride)
|
0 |
C12H16F3N.HCl |
|
|
|
| GC46603-50mg |
|
— |
3-methyl-α-Pyrrolidinopropiophenone (hydrochloride)
|
0 |
C14H19NO.HCl |
|
|
|
| GC46603-10mg |
|
— |
3-methyl-α-Pyrrolidinopropiophenone (hydrochloride)
|
0 |
C14H19NO.HCl |
|
|
|
| GC46603-5mg |
|
— |
3-methyl-α-Pyrrolidinopropiophenone (hydrochloride)
|
0 |
C14H19NO.HCl |
|
|
|
| GC46602-50mg |
|
— |
3-Methylethcathinone (hydrochloride)
|
0 |
C12H17NO.HCl |
|
|
|
| GC46602-10mg |
|
— |
3-Methylethcathinone (hydrochloride)
|
0 |
C12H17NO.HCl |
|
|
|
| GC46602-5mg |
|
— |
3-Methylethcathinone (hydrochloride)
|
0 |
C12H17NO.HCl |
|
|
|
| GC46601-1mg |
|
— |
3-Methylcrotonyl-L-carnitine-d3 (chloride)
|
0 |
C12H19D3NO4.Cl |
|
|
|
| GC46601-500μg |
|
— |
3-Methylcrotonyl-L-carnitine-d3 (chloride)
|
0 |
C12H19D3NO4.Cl |
|
|
|
| GC46600-5mg |
|
— |
3-methoxy-4-ethoxy N,N-Diethylpentedrone (hydrochloride)
|
0 |
C18H29NO3.HCl |
|
|
|
| GC46600-1mg |
|
— |
3-methoxy-4-ethoxy N,N-Diethylpentedrone (hydrochloride)
|
0 |
C18H29NO3.HCl |
|
|
|
